Index -
P/E 21.27
EPS (ttm) 3.52
Insider Own 1.13%
Shs Outstand 47.00M
Perf Week -4.13%
Market Cap 3.54B
Forward P/E 13.57
EPS next Y 5.52
Insider Trans -1.29%
Shs Float 46.65M
Perf Month -4.84%
Income 179.00M
PEG 1.52
EPS next Q 0.57
Inst Own 93.95%
Short Float 2.28%
Perf Quarter -12.01%
Sales 2.11B
P/S 1.67
EPS this Y 3.50%
Inst Trans -3.84%
Short Ratio 2.38
Perf Half Y -25.16%
Book/sh 61.02
P/B 1.23
EPS next Y 19.89%
ROA 3.44%
Short Interest 1.06M
Perf Year -9.48%
Cash/sh 7.91
P/C 9.48
EPS next 5Y 14.00%
ROE 6.67%
52W Range 74.89 - 102.50
Perf YTD -11.11%
Dividend Est. 1.73 (2.31%)
P/FCF 10.88
EPS past 5Y -15.86%
ROI 4.15%
52W High -26.89%
Beta 0.86
Dividend TTM 1.60 (2.14%)
Quick Ratio 1.33
Sales past 5Y -2.62%
Gross Margin 23.37%
52W Low 0.07%
ATR (14) 1.85
Dividend Ex-Date Nov 29, 2024
Current Ratio 2.44
EPS Y/Y TTM 7.87%
Oper. Margin 5.30%
RSI (14) 35.42
Volatility 2.44% 2.05%
Employees 3200
Debt/Eq 0.51
Sales Y/Y TTM -3.51%
Profit Margin 8.47%
Recom 1.40
Target Price 96.00
Option/Short Yes / Yes
LT Debt/Eq 0.50
EPS Q/Q 433.16%
Payout 46.75%
Rel Volume 0.83
Prev Close 75.87
Sales Surprise -0.40%
EPS Surprise -1.75%
Sales Q/Q 0.97%
Earnings Nov 06 AMC
Avg Volume 445.97K
Price 74.94
SMA20 -3.24%
SMA50 -8.52%
SMA200 -17.40%
Trades
Volume 368,694
Change -1.23%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-24 Upgrade
JP Morgan
Underweight → Neutral
$90 → $89
Apr-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$100 → $112
Mar-14-24 Upgrade
Jefferies
Hold → Buy
$100 → $126
Mar-01-24 Initiated
Wolfe Research
Outperform
$108
Jun-29-23 Downgrade
Evercore ISI
Outperform → In-line
Jun-26-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$109 → $90
Feb-02-23 Downgrade
JP Morgan
Neutral → Underweight
$104 → $105
Sep-12-22 Initiated
Credit Suisse
Outperform
$120
Jan-20-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $110
Nov-11-21 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Oct-13-21 Initiated
Mizuho
Buy
$116
Jul-30-21 Upgrade
JP Morgan
Underweight → Neutral
$90
Jun-18-21 Initiated
Stifel
Buy
$118
May-04-21 Downgrade
JP Morgan
Neutral → Underweight
$88 → $89
Mar-15-21 Resumed
Credit Suisse
Outperform
$103
Feb-05-21 Reiterated
Monness Crespi & Hardt
Buy
$88 → $100
Sep-22-20 Initiated
Evercore ISI
In-line
Jul-30-20 Reiterated
Monness Crespi & Hardt
Buy
$80 → $88
May-07-20 Upgrade
JP Morgan
Underweight → Neutral
$68 → $62
Apr-17-20 Reiterated
Monness Crespi & Hardt
Buy
$88 → $80
Show Previous Ratings
Dec-09-24 05:01PM
06:30AM
Nov-21-24 01:00AM
Nov-14-24 07:00AM
Nov-08-24 07:00AM
02:16AM
Loading…
02:16AM
Nov-06-24 07:15PM
06:27PM
(Associated Press Finance)
05:00PM
07:09AM
Nov-05-24 09:15AM
07:40AM
Oct-31-24 12:22PM
Oct-28-24 05:00PM
Oct-09-24 10:40AM
07:31AM
Loading…
Oct-07-24 07:31AM
Sep-19-24 10:06AM
Sep-16-24 07:00AM
Sep-03-24 07:00AM
07:00AM
07:00AM
Sep-01-24 10:04PM
Aug-28-24 08:04PM
Aug-25-24 01:53PM
(The Wall Street Journal)
Aug-23-24 09:40AM
Aug-09-24 05:01PM
Aug-07-24 09:40AM
06:55AM
Aug-06-24 05:31PM
(Associated Press Finance)
05:01PM
09:40AM
Loading…
Aug-05-24 09:40AM
Jul-25-24 04:39PM
Jul-17-24 07:00AM
Jun-24-24 07:00AM
Jun-18-24 07:00AM
Jun-04-24 08:00AM
May-30-24 11:31AM
May-17-24 09:25AM
May-09-24 11:03AM
May-08-24 05:01PM
09:50AM
May-07-24 05:01PM
07:00AM
06:59AM
May-06-24 09:40AM
May-02-24 04:02PM
08:45AM
03:17AM
May-01-24 04:52PM
Apr-30-24 09:53PM
06:32PM
05:13PM
(Associated Press Finance)
05:01PM
Apr-18-24 06:59AM
Apr-15-24 06:59AM
Apr-11-24 11:13AM
Apr-03-24 05:01PM
Mar-28-24 04:05PM
Mar-08-24 06:59AM
Feb-29-24 11:30AM
Feb-06-24 12:20PM
Feb-01-24 10:12AM
01:20AM
(Thomson Reuters StreetEvents)
Jan-31-24 07:17PM
10:54AM
Jan-30-24 07:00PM
05:42PM
05:11PM
(Associated Press Finance)
05:01PM
Jan-29-24 09:16AM
Jan-22-24 05:01PM
Jan-16-24 05:00PM
Jan-09-24 07:00AM
Dec-08-23 11:30AM
Dec-04-23 07:00AM
Nov-30-23 07:00AM
Nov-23-23 01:04PM
Nov-21-23 12:20PM
07:00AM
Nov-14-23 05:25PM
Nov-13-23 05:00PM
Nov-09-23 06:55AM
Nov-08-23 07:55PM
(Associated Press Finance)
05:58PM
05:00PM
Nov-01-23 05:00PM
Oct-26-23 06:01AM
Oct-25-23 06:23AM
Sep-26-23 06:01AM
Sep-12-23 11:33AM
Aug-28-23 07:00AM
Aug-26-23 12:57PM
Aug-25-23 08:09AM
04:30AM
Aug-24-23 06:14AM
Aug-17-23 05:00PM
07:57AM
05:00AM
Aug-16-23 05:51AM
Aug-14-23 07:00AM
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BONI ERIC N VP, Finance & Prinpl Acctg Off Dec 05 '24 Sale 78.07 451 35,210 14,182 Dec 09 05:15 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Dec 04 '24 Option Exercise 59.95 451 27,037 14,633 Dec 05 05:00 PM BONI ERIC N Officer Dec 05 '24 Proposed Sale 78.07 451 35,210 Dec 05 09:53 AM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 19 '24 Option Exercise 76.39 418 31,931 3,641 Nov 20 04:30 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 19 '24 Sale 75.54 162 12,237 3,354 Nov 20 04:30 PM MUSA OSAMA M SVP and CTO Nov 19 '24 Option Exercise 76.39 1,878 143,460 27,288 Nov 20 04:30 PM BOSTAPH KARL R. Senior VP Operations Nov 19 '24 Option Exercise 76.39 418 31,931 7,165 Nov 20 04:30 PM Drury Eileen SVP and Chief HRO Nov 19 '24 Option Exercise 76.39 911 69,591 6,606 Nov 20 04:30 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 19 '24 Option Exercise 76.39 450 34,376 14,312 Nov 20 04:30 PM WILLIS J KEVIN SVP and CFO Nov 19 '24 Option Exercise 76.39 3,486 266,296 234,324 Nov 20 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Nov 19 '24 Option Exercise 76.39 11,096 847,623 131,382 Nov 20 04:30 PM WILLIS J KEVIN SVP and CFO Nov 18 '24 Option Exercise 77.03 3,860 297,336 231,649 Nov 19 05:06 PM NOVO GUILLERMO Chair of the Board and CEO Nov 18 '24 Option Exercise 77.03 12,639 973,582 122,778 Nov 19 04:42 PM Drury Eileen SVP and Chief HRO Nov 18 '24 Option Exercise 77.03 1,101 84,810 5,956 Nov 19 04:42 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 18 '24 Option Exercise 77.03 486 37,437 3,293 Nov 19 04:41 PM MUSA OSAMA M SVP and CTO Nov 18 '24 Option Exercise 77.03 2,081 160,299 25,751 Nov 19 04:41 PM BOSTAPH KARL R. Senior VP Operations Nov 18 '24 Option Exercise 77.03 638 49,145 6,888 Nov 19 04:40 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 18 '24 Option Exercise 77.03 510 39,285 13,931 Nov 19 04:39 PM LAMPKIN ROBIN E. Officer Nov 19 '24 Proposed Sale 75.54 162 12,237 Nov 19 10:12 AM MUSA OSAMA M SVP and CTO Nov 14 '24 Option Exercise 78.05 2,031 158,520 24,776 Nov 18 05:36 PM BOSTAPH KARL R. Senior VP Operations Nov 14 '24 Option Exercise 78.05 1,054 82,265 6,728 Nov 18 05:35 PM Drury Eileen SVP and Chief HRO Nov 14 '24 Option Exercise 78.05 1,258 98,187 5,711 Nov 18 05:34 PM WILLIS J KEVIN SVP and CFO Nov 14 '24 Option Exercise 78.05 3,771 294,327 230,497 Nov 18 05:34 PM NOVO GUILLERMO Chair of the Board and CEO Nov 14 '24 Option Exercise 78.05 8,865 691,913 116,649 Nov 18 05:33 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 14 '24 Option Exercise 78.05 1,238 96,626 4,121 Nov 18 05:33 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 15 '24 Sale 77.90 868 67,617 2,883 Nov 18 05:33 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 14 '24 Option Exercise 78.05 1,190 92,880 2,126 Nov 18 05:32 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 14 '24 Option Exercise 78.05 602 46,986 13,674 Nov 18 05:31 PM LAMPKIN ROBIN E. Officer Nov 15 '24 Proposed Sale 77.90 868 67,617 Nov 15 01:19 PM WILLIS J KEVIN SVP and CFO Sep 03 '24 Option Exercise 59.95 5,487 328,946 22,539 Sep 05 04:30 PM WILLIS J KEVIN SVP and CFO Sep 04 '24 Sale 87.88 5,487 482,198 17,052 Sep 05 04:30 PM WILLIS J KEVIN Officer Sep 04 '24 Proposed Sale 87.88 5,487 482,198 Sep 04 11:14 AM MINICUCCI JAMES P. SVP and GM, Personal Care May 08 '24 Option Exercise 97.56 1,364 133,072 1,364 May 20 04:15 PM MUSA OSAMA M SVP and CTO May 08 '24 Option Exercise 59.56 9,698 577,632 27,861 May 09 07:37 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Feb 16 '24 Sale 92.54 844 78,104 2,883 Feb 20 04:15 PM CHONG MIN SVP, Gen. Mgr. Jan 02 '24 Option Exercise 83.70 6,900 577,530 14,800 Jan 04 06:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite